Salarius Pharmaceuticals granted additional extension to regain Nasdaq compliance Salarius Pharmaceuticals granted additional extension to regain Nasdaq compliance Post ContentslrxRead More You might also be interested in reading Bitfarms Increases Revenues by Almost 400% in Q2. July 14, 2025 In Mainstream ← Previous post Next post →